UTHR insider transactions
United Therapeutics Corporation (UTHR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for UTHR
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,043,689 worth of shares (9,500 units at $530.91) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,038,340 worth of shares (9,500 units at $530.35) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,429,638 worth of shares (8,300 units at $533.69) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,004,909 worth of shares (9,500 units at $526.83) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,091,949 worth of shares (9,500 units at $535.99) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Giltner Richard converted options into 1,310 shares, increasing direct ownership by 6% to 21,884 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Kurzweil Ray converted options into 650 shares, increasing direct ownership by 5% to 13,320 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Mesa Nilda converted options into 650 shares, increasing direct ownership by 13% to 5,678 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Olian Judy D. converted options into 1,310 shares, increasing direct ownership by 31% to 5,555 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Patusky Christopher converted options into 650 shares, increasing direct ownership by 44% to 2,140 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Sullivan Louis W converted options into 650 shares, increasing direct ownership by 28% to 2,983 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,173,660 worth of shares (9,500 units at $544.60) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Malcolm Jan converted options into 650 shares and sold $178,942 worth of shares (325 units at $550.59) as part of a pre-agreed trading plan, increasing direct ownership by 260% to 450 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,235,756 worth of shares (9,500 units at $551.13) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,255,111 worth of shares (9,500 units at $553.17) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,309,296 worth of shares (9,500 units at $558.87) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,215,133 worth of shares (9,500 units at $548.96) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,268,781 worth of shares (9,500 units at $554.61) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,586,275 worth of shares (8,300 units at $552.56) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,164,789 worth of shares (9,500 units at $543.66) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,139,542 worth of shares (9,500 units at $541.00) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,185,133 worth of shares (9,500 units at $545.80) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,167,734 worth of shares (9,500 units at $543.97) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,228,773 worth of shares (9,500 units at $550.40) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,212,520 worth of shares (9,500 units at $548.69) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,167,571 worth of shares (9,500 units at $543.95) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $138.67 and sold $5,108,527 worth of shares (9,500 units at $537.74) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 8,750 shares at a strike of $146.03 and sold $4,708,786 worth of shares (8,750 units at $538.15) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $146.03 and sold $5,401,488 worth of shares (10,000 units at $540.15) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,131,711 worth of shares (9,500 units at $540.18) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A sold $4,494,841 worth of shares (8,300 units at $541.55) as part of a pre-agreed trading plan and exercised 8,300 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,247,802 worth of shares (9,500 units at $552.40) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,223,068 worth of shares (9,500 units at $549.80) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,216,918 worth of shares (9,500 units at $549.15) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,491,742 worth of shares (10,000 units at $549.17) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,143,214 worth of shares (9,500 units at $541.39) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,492,894 worth of shares (10,000 units at $549.29) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,217,684 worth of shares (9,500 units at $549.23) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,218,534 worth of shares (9,500 units at $549.32) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,475,045 worth of shares (10,000 units at $547.50) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,201,110 worth of shares (9,500 units at $547.49) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,202,436 worth of shares (9,500 units at $547.62) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,190,128 worth of shares (9,500 units at $546.33) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,462,824 worth of shares (10,000 units at $546.28) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,540,642 worth of shares (8,300 units at $547.07) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,202,271 worth of shares (9,500 units at $547.61) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,114,742 worth of shares (9,500 units at $538.39) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,205,105 worth of shares (9,500 units at $547.91) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,478,663 worth of shares (10,000 units at $547.87) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Amendment: Chairperson & CEO Rothblatt Martine A sold $863,947 worth of shares (1,500 units at $575.96) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 43,153 units (SEC Form 4)4/A - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,261,365 worth of shares (9,500 units at $553.83) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,656,298 worth of shares (10,000 units at $565.63) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,373,592 worth of shares (9,500 units at $565.64) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,466,283 worth of shares (9,500 units at $575.40) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,729,359 worth of shares (10,000 units at $572.94) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $4,579,018 worth of shares (8,000 units at $572.38) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A gifted 9,009 units of Common Stock and gifted 2,060 shares (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,393,558 worth of shares (9,500 units at $567.74) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,641,130 worth of shares (10,000 units at $564.11) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,359,011 worth of shares (9,500 units at $564.11) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)